A Phase 1-2 Open-Label Dose-Finding Proof of Concept First-in-Human Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CX-2009 in Adults with Metastatic or Locally Advanced Unresectable Solid Tumors
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
